Literature DB >> 17418106

Go but not Gi2 or Gi3 is required for muscarinic regulation of heart rate and heart rate variability in mice.

Sheng Zhong Duan1, Michael Christe, David S Milstone, Richard M Mortensen.   

Abstract

Muscarinic receptor-mediated cardiac parasympathetic activity is essential for regulating heart rate and heart rate variability (HRV). It has not been clear which G(i)/G(o) protein is responsible for these effects. We addressed this question using knockout mice that lack G protein alpha(i2), alpha(i3), or alpha(o) specifically. Unlike previously reported, our alpha(o)-null mice had significantly more survivors with normal life span. Isolated hearts from alpha(o)-null mice demonstrated much less sensitivity to the negative chronotropic effects of the muscarinic agonist carbachol to lower heart rate at baseline and a more profound effect under the stimulation of the beta-adrenergic agonist isoproterenol. In the presence of parasympathetic activation indirectly produced by methoxamine, an alpha(1)-adrenergic agonist, alpha(o)-null mice showed markedly decreased HRV compared with wild-type control mice. These differences in heart rate and HRV were not observed in alpha(i2)-null or alpha(i3)-null mice. Our findings establish an essential role for alpha(o) G protein in the anti-adrenergic effect of carbachol on heart rate regulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418106      PMCID: PMC1963439          DOI: 10.1016/j.bbrc.2007.03.130

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Targeted inactivation of alphai2 or alphai3 disrupts activation of the cardiac muscarinic K+ channel, IK+Ach, in intact cells.

Authors:  M O Sowell; C Ye; D A Ricupero; S Hansen; S J Quinn; P M Vassilev; R M Mortensen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Production of homozygous mutant ES cells with a single targeting construct.

Authors:  R M Mortensen; D A Conner; S Chao; A A Geisterfer-Lowrance; J G Seidman
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

3.  Heart rate regulation by G proteins acting on the cardiac pacemaker channel.

Authors:  A Yatani; K Okabe; J Codina; L Birnbaumer; A M Brown
Journal:  Science       Date:  1990-09-07       Impact factor: 47.728

Review 4.  G protein-activated inwardly rectifying potassium channels as potential therapeutic targets.

Authors:  Toru Kobayashi; Kazutaka Ikeda
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  Targeted inactivation of Galpha(i) does not alter cardiac function or beta-adrenergic sensitivity.

Authors:  M Jain; C C Lim; K Nagata; V M Davis; D S Milstone; R Liao; R M Mortensen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-02       Impact factor: 4.733

6.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

7.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

8.  Abnormal heart rate regulation in GIRK4 knockout mice.

Authors:  K Wickman; J Nemec; S J Gendler; D E Clapham
Journal:  Neuron       Date:  1998-01       Impact factor: 17.173

9.  Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease.

Authors:  K H Desai; R Sato; E Schauble; G S Barsh; B K Kobilka; D Bernstein
Journal:  Am J Physiol       Date:  1997-02

10.  Effect of reserpine pretreatment on guinea pig ventricular performance and responsiveness to inotropic agents.

Authors:  R L Rodgers; J H McNeill
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

View more
  13 in total

1.  The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias.

Authors:  Richard Ang; Aaisha Opel; Andrew Tinker
Journal:  Front Physiol       Date:  2012-04-24       Impact factor: 4.566

Review 2.  Molecular mechanisms of go signaling.

Authors:  Meisheng Jiang; Neil S Bajpayee
Journal:  Neurosignals       Date:  2009-02-12

3.  Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80.

Authors:  Isaac J Dripps; Brett T Boyer; Richard R Neubig; Kenner C Rice; John R Traynor; Emily M Jutkiewicz
Journal:  Br J Pharmacol       Date:  2018-02-09       Impact factor: 8.739

4.  μ-Opioid receptor coupling to Gα(o) plays an important role in opioid antinociception.

Authors:  Jennifer T Lamberts; Emily M Jutkiewicz; Richard M Mortensen; John R Traynor
Journal:  Neuropsychopharmacology       Date:  2011-06-08       Impact factor: 7.853

5.  Genetic disruption of G proteins, G(i2)alpha or G(o)alpha, does not abolish inotropic and chronotropic effects of stimulating muscarinic cholinoceptors in atrium.

Authors:  P Boknik; S Grote-Wessels; G Barteska; M Jiang; F U Müller; W Schmitz; J Neumann; L Birnbaumer
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

6.  Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice.

Authors:  Lei Wang; Helmut Hiller; Justin A Smith; Annette D de Kloet; Eric G Krause
Journal:  Physiol Genomics       Date:  2016-07-28       Impact factor: 3.107

Review 7.  Prioritizing the development of mouse models for childhood brain disorders.

Authors:  Kevin K Ogden; Emin D Ozkan; Gavin Rumbaugh
Journal:  Neuropharmacology       Date:  2015-07-29       Impact factor: 5.250

8.  GPCR-dependent biasing of GIRK channel signaling dynamics by RGS6 in mouse sinoatrial nodal cells.

Authors:  Allison Anderson; Ikuo Masuho; Ezequiel Marron Fernandez de Velasco; Atsushi Nakano; Lutz Birnbaumer; Kirill A Martemyanov; Kevin Wickman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

9.  Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence.

Authors:  Jennifer T Lamberts; Lisa D Rosenthal; Emily M Jutkiewicz; John R Traynor
Journal:  Psychopharmacology (Berl)       Date:  2017-10-03       Impact factor: 4.530

10.  The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics.

Authors:  Zia Zuberi; Lutz Birnbaumer; Andrew Tinker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-01       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.